AGF Investments LLC’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-3,134
Closed -$609K – 492
2021
Q1
$609K Sell
3,134
-1,198
-28% -$246K 0.07% 187
2020
Q4
$830K Sell
4,332
-5,027
-54% -$915K 0.1% 111
2020
Q3
$1.38M Sell
9,359
-109
-1% -$15.6K 0.15% 105
2020
Q2
$1.17M Buy
9,468
+9,377
+10,304% +$1.1M 0.12% 210
2020
Q1
$9K Buy
+91
New +$8.79K ﹤0.01% 484

Other funds holding RGEN

AGF Investments LLC's RGEN Position: Q2 2021 in Review

AGF Investments LLC sold out of Repligen (RGEN) in Q2 2021, closing a stake of 3,134 shares — an estimated $609K sold.

AGF Investments LLC first reported a position in RGEN in Q1 2020 and held it in 5 quarters. The position peaked at $1.38M in Q3 2020. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • AGF Investments LLC reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • AGF Investments LLC sold 3,134 Repligen shares in Q2 2021, an estimated $609K.
  • AGF Investments LLC first reported a position in Repligen in Q1 2020 and held it in 5 quarters.
  • AGF Investments LLC's Repligen position peaked at $1.38M in Q3 2020.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on AGF Investments LLC's 13F filing for Q2 2021, filed 12 Aug 2021.